Metabolic dysfunction and male pelvic health.
Kaplan
Steven A
SA
D000069059:Atorvastatin; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008297:Male; D024821:Metabolic Syndrome / Q000503:physiopathology*; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D011758:Pyrroles / Q000627:therapeutic use; D014555:Urination Disorders / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*
D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin